Does Treating RA Before Symptoms Begin Delay the Disease?

Health & LifestyleNews
259

Listen to article (english)

Translate to Spanish or other 102 languages!

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. Image for illustration purposes
As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. 

While the exact cause of rheumatoid arthritis is currently unknown, scientists believe that risk is based on a number of factors, including genetics and environmental factors like smoking. 

- Advertisement -

There is also currently no way to prevent rheumatoid arthritis, especially if it runs in your family. 

Now, a study recently published in the journal has found that treating people at high risk of developing rheumatoid arthritis with a rheumatoid arthritis-specific medication may help delay disease onset for several years.

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/pretreatment-rheumatoid-arthritis-onset-delay-4-years?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-01-29&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
New Data Shows Nursing Homes Strengthening Workforce Despite Ongoing Shortages 
Next article
DHR Health’s Free Seminar on Groundbreaking Treatment Options for Parkinson’s Disease, Feb, 28th

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -